Rémi Martin-Fardon Selected Research

Rémi Martin-Fardon Research Topics

10	Substance-Related Disorders (Drug Abuse) 01/2023 - 04/2002
9	Alcoholism (Alcohol Abuse) 01/2024 - 02/2010
8	Cocaine-Related Disorders (Cocaine Addiction) 01/2021 - 05/2003
3	Opioid-Related Disorders (Opiate Addiction) 10/2023 - 01/2020
3	Sleep Initiation and Maintenance Disorders (Insomnia) 01/2023 - 01/2021
2	Pain (Aches) 01/2023 - 01/2020
2	Shock 05/2013 - 07/2008
1	Respiratory Insufficiency (Respiratory Failure) 10/2023
1	Hyperalgesia 10/2023
1	Substance Withdrawal Syndrome (Withdrawal Symptoms) 01/2023
1	Cognitive Dysfunction 01/2018
1	Dehydration (Water Stress) 07/2017
1	Acute Pain 01/2017
1	Seizures (Absence Seizure) 07/2003

7	Cocaine (Cocaine HCl)IBA 01/2021 - 04/2002
6	OrexinsIBA 01/2022 - 11/2016
6	Ethanol (Ethyl Alcohol)IBA 01/2018 - 07/2003
3	Analgesics (Analgesic Drugs)IBA 10/2023 - 01/2017
3	Oxycodone (Oxycontin)FDA LinkGeneric 10/2023 - 01/2020
3	Opioid Analgesics (Opioids)IBA 01/2023 - 01/2017
3	Orexin ReceptorsIBA 01/2021 - 01/2020
3	Peptides (Polypeptides)IBA 01/2017 - 02/2010
2	suvorexantIBA 01/2023 - 01/2022
2	Orexin Receptor AntagonistsIBA 01/2022 - 01/2021
2	NociceptinIBA 01/2017 - 07/2015
1	Narcotic Antagonists (Opioid Antagonists)IBA 01/2024
1	Histamine (Histamine Dihydrochloride)FDA Link 01/2023
1	NeuropeptidesIBA 01/2021
1	Dimenhydrinate (DMH)FDA LinkGeneric 01/2021
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2020
1	Antidepressive Agents (Antidepressants)IBA 01/2020
1	EndocannabinoidsIBA 01/2018
1	Glutamic Acid (Glutamate)FDA Link 01/2018
1	gamma-Aminobutyric Acid (GABA)IBA 01/2018
1	Dialysis SolutionsIBA 01/2018
1	6'- fluoro- 4',9'- dihydro- N,N- dimethyl- 4- phenylspiro(cyclohexane- 1,1'(3'H)- pyrano(3,4- b)indol)- 4- amineIBA 01/2017
1	Opioid Receptors (Opioid Receptor)IBA 01/2017
1	Urea (Carbamide)FDA LinkGeneric 05/2014
1	Metabotropic Glutamate Receptors (Metabotropic Glutamate Receptor)IBA 12/2011
1	metabotropic glutamate receptor 2IBA 08/2010
1	LY 379268IBA 05/2010
1	Corticotropin-Releasing HormoneIBA 02/2010
1	CannabinoidsIBA 11/2007
1	N- (1- (2- benzo(b)thiophenyl)cyclohexyl)piperidin- 3- olIBA 12/2003
1	NeurosteroidsIBA 05/2003
1	GlucocorticoidsIBA 05/2003

2	Self Administration (Administration, Self) 10/2023 - 01/2022
1	Injections 01/2021
1	Secondary Prevention 07/2015
1	Therapeutics 12/2003